4/A//SEC Filing
O'Toole David D. 4/A
Accession 0001181431-09-013280
CIK 0001409012other
Filed
Mar 2, 7:00 PM ET
Accepted
Mar 3, 9:44 PM ET
Size
6.7 KB
Accession
0001181431-09-013280
Insider Transaction Report
Form 4/AAmended
O'Toole David D.
CFO & Executive VP
Transactions
- Tax Payment
Common Stock
2009-02-03$70.40/sh−134$9,434→ 1,107 total - Award
Common Stock
2009-02-03+1,241→ 1,241 total
Footnotes (1)
- [F1]On February 3, 2009, the reporting person was granted1, 241 restricted stock units, of which 310 units were vested on the date of grant with the remaining units vesting in 2 equal installments on January 15, 2010 and January 15, 2011.
Documents
Issuer
Abraxis BioScience, Inc.
CIK 0001409012
Entity typeother
Related Parties
1- filerCIK 0001437047
Filing Metadata
- Form type
- 4/A
- Filed
- Mar 2, 7:00 PM ET
- Accepted
- Mar 3, 9:44 PM ET
- Size
- 6.7 KB